Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA

Rosanna Asselta, Valeria Rimoldi, Ilaria Guella, Giulia Soldà, Raimondo De Cristofaro, Flora Peyvandi, Stefano Duga

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Alternative splicing of pre-mRNAs is a central process to the generation of proteome complexity. However, many alternative mRNA isoforms carry premature termination codons (PTCs) rendering them possible targets for the nonsensemediated mRNA decay (NMD) pathway. The F11 gene consists of 15 exons spanning approximately 23 kb on chromosome 4q35 and codes for coagulation factor XI (FXI), a 160-kDa dimeric zymogen composed of 4 apple domains and a serine protease domain. Here, we characterized the F11 splicing pattern in human liver and platelets identifying multiple inframe and out-of-frame splicing events. Inhibition of NMD resulted in the upregulation of all unproductively spliced F11 transcripts, thus providing evidence that these PTC-containing mRNAs are under the control of NMD. Among inframe alternatively spliced transcripts, the one skipping exons 6 and 7 would lead to the synthesis of a FXI protein lacking 1 apple domain (FXI-Δ6/7). Ex vivo expression in mammalian cells demonstrated that FXI-Δ6/7 is mostly retained intracellularly, and secreted only in low amounts. Traces of this FXI isoform were detectable in human plasma. Our results suggest that the coupling of alternative splicing and NMD may play a role in regulating F11 expression, and point to the existence of a novel FXI isoform.

Original languageEnglish
Pages (from-to)2065-2072
Number of pages8
JournalBlood
Volume115
Issue number10
DOIs
Publication statusPublished - Mar 11 2010

Fingerprint

Factor XI
RNA Precursors
Alternative Splicing
RNA Stability
Messenger RNA
Nonsense Codon
Malus
Exons
Protein Isoforms
RNA Isoforms
Plasma (human)
Enzyme Precursors
Serine Proteases
Proteome
Chromosomes
Platelets
Liver
Up-Regulation
Blood Platelets
Genes

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA. / Asselta, Rosanna; Rimoldi, Valeria; Guella, Ilaria; Soldà, Giulia; De Cristofaro, Raimondo; Peyvandi, Flora; Duga, Stefano.

In: Blood, Vol. 115, No. 10, 11.03.2010, p. 2065-2072.

Research output: Contribution to journalArticle

@article{303539d6d542491d94d13a2a2dac40b5,
title = "Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA",
abstract = "Alternative splicing of pre-mRNAs is a central process to the generation of proteome complexity. However, many alternative mRNA isoforms carry premature termination codons (PTCs) rendering them possible targets for the nonsensemediated mRNA decay (NMD) pathway. The F11 gene consists of 15 exons spanning approximately 23 kb on chromosome 4q35 and codes for coagulation factor XI (FXI), a 160-kDa dimeric zymogen composed of 4 apple domains and a serine protease domain. Here, we characterized the F11 splicing pattern in human liver and platelets identifying multiple inframe and out-of-frame splicing events. Inhibition of NMD resulted in the upregulation of all unproductively spliced F11 transcripts, thus providing evidence that these PTC-containing mRNAs are under the control of NMD. Among inframe alternatively spliced transcripts, the one skipping exons 6 and 7 would lead to the synthesis of a FXI protein lacking 1 apple domain (FXI-Δ6/7). Ex vivo expression in mammalian cells demonstrated that FXI-Δ6/7 is mostly retained intracellularly, and secreted only in low amounts. Traces of this FXI isoform were detectable in human plasma. Our results suggest that the coupling of alternative splicing and NMD may play a role in regulating F11 expression, and point to the existence of a novel FXI isoform.",
author = "Rosanna Asselta and Valeria Rimoldi and Ilaria Guella and Giulia Sold{\`a} and {De Cristofaro}, Raimondo and Flora Peyvandi and Stefano Duga",
year = "2010",
month = "3",
day = "11",
doi = "10.1182/blood-2009-09-245092",
language = "English",
volume = "115",
pages = "2065--2072",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - Molecular characterization of in-frame and out-of-frame alternative splicings in coagulation factor XI pre-mRNA

AU - Asselta, Rosanna

AU - Rimoldi, Valeria

AU - Guella, Ilaria

AU - Soldà, Giulia

AU - De Cristofaro, Raimondo

AU - Peyvandi, Flora

AU - Duga, Stefano

PY - 2010/3/11

Y1 - 2010/3/11

N2 - Alternative splicing of pre-mRNAs is a central process to the generation of proteome complexity. However, many alternative mRNA isoforms carry premature termination codons (PTCs) rendering them possible targets for the nonsensemediated mRNA decay (NMD) pathway. The F11 gene consists of 15 exons spanning approximately 23 kb on chromosome 4q35 and codes for coagulation factor XI (FXI), a 160-kDa dimeric zymogen composed of 4 apple domains and a serine protease domain. Here, we characterized the F11 splicing pattern in human liver and platelets identifying multiple inframe and out-of-frame splicing events. Inhibition of NMD resulted in the upregulation of all unproductively spliced F11 transcripts, thus providing evidence that these PTC-containing mRNAs are under the control of NMD. Among inframe alternatively spliced transcripts, the one skipping exons 6 and 7 would lead to the synthesis of a FXI protein lacking 1 apple domain (FXI-Δ6/7). Ex vivo expression in mammalian cells demonstrated that FXI-Δ6/7 is mostly retained intracellularly, and secreted only in low amounts. Traces of this FXI isoform were detectable in human plasma. Our results suggest that the coupling of alternative splicing and NMD may play a role in regulating F11 expression, and point to the existence of a novel FXI isoform.

AB - Alternative splicing of pre-mRNAs is a central process to the generation of proteome complexity. However, many alternative mRNA isoforms carry premature termination codons (PTCs) rendering them possible targets for the nonsensemediated mRNA decay (NMD) pathway. The F11 gene consists of 15 exons spanning approximately 23 kb on chromosome 4q35 and codes for coagulation factor XI (FXI), a 160-kDa dimeric zymogen composed of 4 apple domains and a serine protease domain. Here, we characterized the F11 splicing pattern in human liver and platelets identifying multiple inframe and out-of-frame splicing events. Inhibition of NMD resulted in the upregulation of all unproductively spliced F11 transcripts, thus providing evidence that these PTC-containing mRNAs are under the control of NMD. Among inframe alternatively spliced transcripts, the one skipping exons 6 and 7 would lead to the synthesis of a FXI protein lacking 1 apple domain (FXI-Δ6/7). Ex vivo expression in mammalian cells demonstrated that FXI-Δ6/7 is mostly retained intracellularly, and secreted only in low amounts. Traces of this FXI isoform were detectable in human plasma. Our results suggest that the coupling of alternative splicing and NMD may play a role in regulating F11 expression, and point to the existence of a novel FXI isoform.

UR - http://www.scopus.com/inward/record.url?scp=77950433462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950433462&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-09-245092

DO - 10.1182/blood-2009-09-245092

M3 - Article

C2 - 20042724

AN - SCOPUS:77950433462

VL - 115

SP - 2065

EP - 2072

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -